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Abstract
This thesis focuses on the three different projects that I worked on during my time in Dr. Yvonne Sun’s
microbiology lab. The main goal of the first project was to develop an analytical method on UD’s campus
to analyze SCFAs by using Gas Chromatography. This was achieved by creating defined media that could
sustain the growth of Listeria monocytogenes (Listeria) and developing a successful characterization
method on a GC. The main goal of the second project was to determine the effects that SCFA
supplementation and age have on Listeria infection. This was achieved using in vitro methods to assess the
effects of SCFAs on LLO production, acetoin production, and cell culture infection and in vivo methods to
assess the effects of SCFAs and age on mice with Listeria infections. The main goal of the third project
was to gain a better understanding of the mechanism underlying the regulation of Listeria’s LLO
production by varying oxygen levels. This was achieved by performing aerobic/anaerobic transition
experiments and aerobic/microaerobic/anaerobic experiments.
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Project 1 – The Human Gut Microbiome, Microbial Metabolites,
and the Development of Analytical Techniques of SCFA Analysis
Introduction
The Significance of the Human Gut Microbiome on Human Health
The human gut microbiome has a much larger impact on human health than
previously known. One example of this involves obesity, which plagues much of our
world today. According to the CDC, every state in the U.S. had 20% or more of its adult
population classified as obese in 2016. In some states, such as Alabama, the percentage
jumped to 35% or more.1 Obesity is connected with decreased variety of gut bacteria,
which in turn is associated with higher levels of systematic inflammation.2 Because this
inflammation plays a role in the development of some cancers, it is likely that the gut
microbiota have contributed to a connection between adiposity and gastrointestinal
cancers.3
The impact that the gut microbiome has on health is further established in our
understanding on the gut-brain axis. The gut-brain axis is the signaling pathway between
the gastrointestinal tract (gut) and central nervous system. However, despite the
recognition and awareness of the gut microbiota as a key factor in human health, whether
the relationship is correlative or causal is difficult to establish. Using rodents as
experimental hosts, the gut microbiome was shown to play a role in modifying emotional
behavior. Bifidobacterium and Lactobacillus have both been shown to exert positive
effects on anxious and depression-like behavior.4 In human studies, children with autism
spectrum disorder (ASD) have reduced protein digestion, which results in higher amounts
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of peptides going into circulation and the distal gastrointestinal tract.5 This could cause
dysbiosis, which is a lack of harmony between the beneficial and harmful species in the
gut.5 Dysbiosis could cause changed immune reactions and higher danger of diseases.6 It
has also been suggested that gastrointestinal issues, which could be linked to dysbiosis,
may have a causal relationship with ASD because of the frequency that children with
ASD have had GI issues.7
Alterations in diet, which consequentially alter the gut microbiota, are known to
play a role in autoimmune diseases (like multiple sclerosis).8 For example, high
consumption of salt could be a factor in autoimmune disease development because of
certain pathogenic cell induction.9 The human gut microbiota plays a key role in priming
the immune system in multiple ways, such as providing immune-stimulatory signals,
which may trigger immune responses.8 Not only does the gut microbiota influence the
immune system, but the immune system also controls the composition of the
microbiota.10

Mechanisms of Microbiome Effect on Human Health
Trimethylamine N-oxide (TMAO) is an example of an intestinal metabolite that
impacts human cardiovascular health. TMAO is derived from choline and
phosphatidylcholine in one’s diet.11 Choline is first metabolized to trimethylamine
(TMA) by the gut microbiota, and TMA is in turn converted to TMAO by FMO3, which
is an enzyme in the liver.12 Interestingly, higher amounts of TMAO have been associated
with higher risk of adverse cardiovascular events13 because this TMA/FMO3/TMAO
pathway regulates inflammation and lipid metabolism in many different ways11 that result
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in deposit of fatty materials in the artery linings, or atherosclerosis. TMAO promotes
expression of scavenger receptors in macrophages to increase their proinflammatory
responses. TMAO also significantly alters cholesterol and sterol metabolism by altering
bile acid synthesis and cholesterol transport.14 Moreover, because phosphocholines are
enriched in red meat, subjects that had a combined meat-plant based diet produced more
TMAO than those with only a plant based diet following the same ingestion.14 As a result
of this research field, the gut microbiota has demonstrated a direct role in contributing to
cardiovascular disease.
Other examples of metabolites that impact health are long chain fatty acids
(LCFAs) and short chain fatty acids (SCFAs). The fascinating thing about these
molecules is a minor difference in chain length can have a large impact on their health
consequences in the human body. LCFAs, which are microbial metabolites found in large
quantities in the modern western diet, may be an underlying cause of diseases because
they promote differentiation and proliferation of T helper 1 (Th1) and/or T helper 17
(Th17) cells and diminish sequestration of Th1 and Th17 cells in the intestines. SCFAs
are metabolites produced by microbial fermentation in the intestines and play multiple
roles in benefiting our health.15 They are able to play a role in the human metabolic
regulation, immune homeostasis, and the performance of the nervous system through the
activation of G-protein coupled receptors (GPCRs).16 SCFAs are the ligands of the
GPCRs free fatty acid receptors 2 and 3 (FFA2 and FFA3). FFA2 has been found to alter
the supply of gut immune cells and inflammatory responses that manage immune
homeostasis and protect the epithelial wall of the intestine against tumor development
and pathogens, and both FFA2 and FFA3 regulate glucose homeostasis.17
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What SCFAs Are and How They Are Synthesized
SCFAs are fatty acids consisting of only 2-6 carbons, making them highly
difficult to analyze in complex biological samples. They are metabolites produced by
microbial fermentation of polysaccharides, starches, and endogenous glycans.16 Only
specific species of bacteria can carry out this fermentation to produce SCFAs, such as
Firmicutes and Bacteroidetes.16 The most abundant SCFAs produced are acetic acid
(C2), propionic acid (C3), and butyric acid (C4), with each usually being produced by a
different pathway. The most effective pathway for the production of acetate is the WoodLjungdahl pathway. In this pathway, two molecules of carbon dioxide are reduced to
form a single molecule of acetate.18 Propionate is usually produced by a carbon dioxide
fixation pathway, while butyrate is typically formed by acetyl-S coenzyme A
condensation.19

Methods to Measure SCFAs (Sample Preparation and GC Instrumentation)
Analysis of SCFAs often relies on a gas chromatograph (GC). However, to detect
SCFAs in complex biological samples, sample pretreatment process is required before
injection into the GC for cleaner peaks. Three common cleanup treatments include
extraction,20 ultrafiltration,21,22 and steam distillation.23 Extraction was performed by
suspending fecal samples in water and 50% sulfuric acid. The sample was then
homogenized and centrifuged, creating a supernatant. Using the supernatant and ethyl
ether, an extraction was performed by shaking and venting. The suspension was then
collected and the chosen internal standard (IS) was added before analysis.20 Ultrafiltration
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was performed by homogenizing the fecal sample in sulfuric acid and water. The
homogenized sample was then centrifuged. The supernatant was filtered through a
microconcentrator and then the sample was acidified and distilled using steam
distillation. Acidification and steam distillation steps are used to help with the detection
of the wanted compounds.21 Other literature discussed the use of an ultrafiltration unit.22
Steam distillation was performed by using a microKjeldahl apparatus.23
Successful experimental conditions of the GC are vital for successful separation
and detection of the wanted compounds. Many various methodologies have been reported
and share several common steps. For example, an IS, such as 2-ethyl butyric acid,24,25 is
used for calibration and to adjust for the loss of analyte during analysis in order to obtain
accurate results. In other cases, another 6 carbon chemical is used as the IS.26 A flame
ionization detector (FID) is a common detector used for analyses of SCFAs24,25 because
of its sensitivity, uniform response, and linear range.27 The column used in reported
studies vary; some used a fused-silica capillary column,24,26 and others used a high
polarity capillary column.25 Some columns had a free fatty acid phase (FFAP)24,25 in
order to better analyze SCFAs. The sizes of the columns also varied in internal diameters
– 30m x 0.53mm24,26 and 30m x 0.25mm.25 The film coating thickness varied from
0.5µm,24 0.25µm,25 and 1µm.26 Carrier gases are used in GC as the mobile phase, and
those used include helium24,26 and nitrogen.25 The flow rates of these carrier gases varied
greatly – from 1 mL/min,25 14.4 mL/min,24 to 24 mL/min.26 The detector temperatures
were maintained at 240°C24,25 or 300°C26 to vaporize the analytes. The injection port
temperatures were 200°C24,26 and 220°C.25 In each study, the sample volume used was
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1µL.24–26 Flow rates of hydrogen, air, and nitrogen were 20-30mL/min, 300mL/min, and
20-30mL/min, respectively.24,25

What Listeria monocytogenes Is and why it Is Important
Listeria monocytogenes (Listeria) is a rod-shaped, Gram-positive, facultative
anaerobic bacterium,28 and also a foodborne pathogen that causes listeriosis. Listeriosis
cases are generally infrequent in humans, but the mortality rate for those infected is about
20%, making it an extremely dangerous disease. According to data from 2010, Listeria
infection caused 5,463 deaths, 23,150 illnesses, and172,823 disability-adjusted life-years
(which is the measure of the burden of an illness shown by years of life lost).29 Listeria is
capable of surviving through food treatment and packaging because it can still propagate
in harsh conditions, such as in temperatures of 1.7-45.0°C,30 in a pH range of 4.7-9.2,31
and microaerobic or anaerobic environments. Listeria, as an enteric pathogen, transits
through anaerobic intestinal lumen rich with SCFAs. However, we knew very little about
how the bacteria respond to SCFAs or how SCFAs affect Listeria pathogenesis. Better
understanding of the relationship between SCFAs and Listeria may identify novel
preventative or therapeutic strategies.

Project Goals
The main goal of this project it to establish an analytical method for SCFA
analysis. Although various methods have been established in literature, including Gas
Chromatography, Mass Spectrometry, coupled Gas Chromatography-Mass Spectrometry,
and High-performance Liquid Chromatography, there are no established methods on the
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University of Dayton’s campus. Gas Chromatography is the most readily available option
in Dr. Erick Vasquez’s laboratory and was chosen for this project.

Materials and Methods
Strains
The Listeria strain used in this project was the wild-type lab strain 10403s. This
strain was streaked onto brain heart infusion (BHI) agar weekly.

Defined Media
Listeria is typically grown in complex medias such as brain heart infusion (BHI).
However, accurate detection of SCFAs produced by Listeria requires the creation of a
defined media. Defined media is able to sustain growth of a specific organism while only
consisting of known chemical components. The defined media for this study had to
contain no SCFAs as to not interfere with results of SCFA levels in the samples. After a
thorough search through the relevant literature, modified Welshimer’s broth (MWB)32
and a defined solid and liquid medium (HTM)33 were chosen as the baselines for the
defined media. MWB was found to support only some growth of the strain 10403s,34 and
was thus altered into HTM. Ammonium sulfate was included in HTM and our defined
media because Listeria is able to use inorganic nitrogen sources. Therefore, ammonium
sulfate can replace glutamine in the defined media.33 Because we wanted to develop
defined media that support robust bacterial growth instead of identifying essential
nutritional requirements, we decided to combine the two lists and used higher
concentrations whenever possible. Double the concentration of components of MWB and
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HTM were used in the defined media, except for thiamine, riboflavin, and biotin, where
50 times, 50 times, and 200,000 times the previous concentrations were used,
respectively. Comparisons of the content in MWB, HTM, and our defined media are
shown in Table 1. The final solution was filter sterilized instead of autoclaved to avoid
degradation of amino acids or caramelization of glucose.

Table 1: Content of MWB, HTM, and our defined
media. Empty spots in the table indicate that the
chemical was not used in that media.

Culture Conditions
Listeria strain 10403s was grown overnight in the filter sterilized defined media
described above along with a brain heart infusion (BHI) control. The overnight cultures
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were put into either an aerobic or anaerobic environment. The aerobic cultures were
placed into a 37°C incubator on a shaker while the anaerobic cultures were placed into an
anaerobic chamber and grown statically at 37°C (Type A, Coy Laboratory, Grass Lake,
MI, USA). The gas inside the chamber is mainly nitrogen with 2.5% hydrogen. In each
environment, there were cultures consisting of 1mL of media. Optical density (OD) of the
overnight cultures were read the next day by transferring 200µL of each into a 96-well
plate that was read at 600nm using a 96-well plate reader (Synergy4, Biotek, Winooski,
VT, USA).

Gas Chromatograph Instrumentation
The process to determine the GC instrumentation was also based on trial, error,
and adjustment. In the first trial, a thermal conductivity detector (TCD), water as the
SCFA solvent, and an Rtx-1 column were used. This trial yielded poor results and we
determined this could have been because a TCD is not a suitable detector for SCFAs. The
detector that was then put in was an FID, which has more capabilities for detecting
SCFAs. After the second trial, it was realized that the results were unusable because
water was used as the SCFA solvent. In order to analyze complex biological samples in
the future, the GC method needed to have analyzed standards in the same solvent that
would be used for the complex samples. Because extractions of biological samples would
take place in diethyl ether, this solvent was used from then on for the SCFAs. The third
trial yielded poor results and we determined this was likely because the Rtx-1 column
was nonpolar. In order to separately elute the polar SCFAs, a polar column needed to be
put into place. This is when we installed the DB-FATWAX UI column, which was
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nonpolar and had a FFAP, so it was better equipped to analyze SCFAs. At this point, an
FID, diethyl ether as the SCFA solvent, and the DB-FATWAX UI column were used to
run a fourth trial. This trial yielded excellent results.
*More detailed information on the GC characterization method is not currently available
due to lack of access to research materials during the COVID-19 quarantine.

SCFA Samples and Standards
The SCFA samples were made using the ethyl ether, IS (which consisted of 88%
2-ethylbutyric acid and 12% formic acid), and sodium acetate, sodium propionate, and/or
sodium butyrate. The standards were made in the same way, but the concentration of each
SCFA varied so that a standard graph could be created.
*More detailed information on the creation of the SCFA samples and standards is not
currently available due to lack of access to research materials during the COVID-19
quarantine.

Results
Defined Media Supported the Growth of Listeria
The process to accurately create the defined media was extensive and initially full
of error. It was not realized until after the first few trials that MOPS needed to be adjusted
to pH 7.4, as it is naturally more acidic. Other initial errors included a lack of consistency
in the amount of substance being transferred. However, by the eleventh trial, accurate
defined media was created and gave consistent results when tested, as shown in Figure 1.
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In the last 4 trials, especially trials 10 and 11, Listeria grew slightly better in the presence
of oxygen than it did in the absence of oxygen, which are typically found when Listeria is
grown in BHI (data not shown).

Figure 1: Consistency of OD (read at 600nm) measurements across 11 trials was used
to assess the effectiveness of our defined media to reliably serve as a growth media
for Listeria. The results show the averages of three replicates.

SCFA Characterization Method Established
A clear gas chromatogram was obtained once the GC characterization method had
been adjusted through trial and error. An optimal gas chromatogram has clear, sharp, and
separate peaks for each compound with minimal noise. This was obtained through our
method, as we were able to get results that show the elution of acetate, propionate,
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butyrate, and the IS from left to right. Acetate, propionate, and butyrate each had about
10.137, 11.288, and 12.405 minutes of retention time. Acetate eluted before propionate
and butyrate because it is the most polar of the SCFAs and a polar column was used in
the GC. Once the characterization method was able to accurately detect and elute the
SCFAs, standards were successfully analyzed in order to generate equations that could be
used to find the concentrations of SCFAs in unknown samples.

Discussion
While creating a viable defined media, a couple of important factors to
microbiological research were realized. One of these is that when working with small
amounts of chemicals, the slightest variations in transfer and measurement methods can
impact the results. Another factor was that it is important to adjust pH in media that
bacteria are grown in, because although Listeria is able to grow in a wide pH range, it
may grow optimally at a certain pH. Once these factors were improved, the defined
media appropriately supported Listeria growth.
The most important outcomes of this project are that we have 1) developed a
defined media that does not contain SCFA and is capable of supporting the growth of
Listeria and 2) established an analytical method that is capable of separately eluting
different SCFAs and giving accurate data that can be used to determine SCFA
concentrations in a standard sample. From this method, the standard equations, and the
approximate retention times of the SCFAs, we are now able to able to begin analyzing
complex biological samples.
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Future Directions
In future work on this project, further improvement of the defined media may
prove useful. In our defined media, two buffers were used instead of one, which may
have impacted the growth of Listeria. Now that an accurate analytical method has been
established on the GC for the analysis of SCFAs, more complex biological samples can
be tested such as the production of SCFAs by Listeria and animals. This could be very
valuable to our lab as we work to better understand the influence that SCFAs have on
Listeria infections and human health.

Project 2 – Effects of SCFA and Age on Listeria Pathogenesis
Introduction
Background on Listeriosis
Listeria is able to effectively infect the body by evading immune detection in a
host in a variety of different ways. One way is by cell-to-cell infection, which allows
Listeria to avoid detection outside of cells while continuing to spread. Another way that
Listeria evades immune detection is by targeting host T cells. By targeting host T cells
during Listeria infection, inflammation and innate immunity are repressed.35 Listeria
produces the toxin LLO which induces apoptosis of T cells.36–38 Listeria can evade innate
immune detection by altering components of its cell wall in order to avoid binding with
pattern recognition receptors. One way that Listeria does this is by deacetylating the Nacetylglucosamine residues in its peptidoglycan, thus decreasing its sensitivity to
lysozyme.39 Another way that Listeria evades immune detection is by modifying host
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gene expression. An example of this is alterations to histones H3 and H4 during early
infection, which correlates with decreased transcription of host immunity genes.40
The elderly population is characterized by compromised immune systems, lending
to even higher susceptibility to infection by Listeria. A study has shown the impact of
Listeria on the elderly, as the risk of infection of Listeria increases with age in adults ≥65
years old.41 Although the average annual rate of infection for Listeria is lower than that of
Salmonella and Campylobacter, the percentage of patients hospitalized was higher in
patients with Listeria. Salmonella and Listeria were shown as the leading causes of death
in the study, but percentage of deaths was increased 10-fold in patients with Listeria.41
Because studies have suggested that T cell response impacts human susceptibility to
listeriosis,42,43 further studies have been conducted examining factors such as T cell
response in aging murine models of listeriosis. A study found that aging mice usually
have an increased baseline of Treg responses, and when infected by Listeria, this effect is
only exacerbated. This causes a decrease in pro-inflammatory responses during infection,
which leads to decreased pathogen elimination from systemic organs. The study also
found that T cell expression of CD39 and CD73 is augmented in aging mice.44 In
humans, increased expression of CD39 has been found to possibly impair formation of
vaccine-specific memory T cells.45

Listeria-associated Infective Endocarditis
In some patients, Listeria infections are able to travel to the heart and cause
infective endocarditis. This is a serious form of infection, as patients with endocarditis
due to Listeria have been found to have a 41% mortality rate. This mortality rate is twice
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as high as that of endocarditis associated with other related pathogens, and notably 10
times higher than that of Streptococcus-associated endocarditis.46 Listeria-associated
endocarditis tends to cause severe symptoms, as 50% of patients are found to have acute
congestive heart failure.47 Because of the severity of this type of infection, research has
been done recently to determine whether certain Listeria isolates have enhanced
capability to colonize heart tissue. A study by Alonzo et al. (2011) found this increased
capability of myocardial invasion in a cardiac case isolate (07PF0776). In this study, 10times as many bacteria were recovered from heart tissue in mice infected by the
07PF0776 strain than the 10403s strain that is typically studied.48

Varying SCFA Concentrations Influences Pathogenesis
As stated previously, SCFAs are primarily the result of microbial fermentation in
the gut. SCFA concentrations vary at different locations of the gut, with two notably
distinct locations being the distal ileum and the colon. The distal ileum contains about
25.5mM acetate, 2.25mM propionate, and 2.25mM butyrate, while the colon contains
about 110mM acetate, 70mM propionate, and 20mM butyrate.49 It is thought that SCFA
may signal for bacterial invasion of the ileum while lowering invasion of the colon. An
example of findings consistent with this mechanism come from a Lawhon et al. (2002)
study that investigated the role SCFAs and the sensor kinase BarA had in Salmonella
invasion. It was found that invasion gene expression is restored in barA mutants grown in
SCFA solutions mimicking ileal conditions. However, this restoration does not take place
in barA mutants grown in SCFA solutions mimicking colonial conditions, and. However,
colonic SCFA conditions do not have this restorative effect in barA mutants and reduce
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invasion gene expression in the wild-type strain.49 These results may explain why
Salmonella tend to invade the distal ileum and show the importance of examining the
impact of ileal and colonic SCFA conditions on the pathogenesis of Listeria.

Project Goals
The main goal of this project is to determine the effects of SCFA and age on
Listeria infection. This is done partially through in vitro methods by assessing the effects
of SCFAs on LLO production, acetoin production, and cell culture infection. Oral
infection of mice is also used to give an in vivo approach to assessing the effects of
SCFAs and age on Listeria infection.

Materials and Methods
Strains
The Listeria strains used include the wild-type lab strain 10403s and a clinically
isolated cardiotropic strain 07PF0776 (provided by Dr, Nancy Freitag at The University
of Illinois College of Medicine). These strains were streaked onto brain heart infusion
(BHI) agar weekly.

Mhi and Mlo SCFA Supplementation
Two SCFA mixtures that were mentioned in a previous study49 are used in this
study as a way to study the effects of relevant SCFA concentrations in the body. The
colonic conditions have a higher concentration of SCFAs and the ileal condition have a
lower concentration of SCFAs, so they are respectively labelled Mixturehi (Mhi) and
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Mixturelo (Mlo) in this study. Mhi consists of 110mM acetate, 70mM propionate, and
20mM butyrate, while Mlo consists of 25.5mM acetate, 2.25mM propionate, and 2.25mM
butyrate.

Acetoin Assay
A modified Voges-Proskauer test was used to quantify the acetoin production in
Listeria cultures. 100µL of acetoin standard or culture supernatant was combined with
70µL of 0.5% creatine monohydrate (C3630-100G, Sigma, St. Louis, MO, USA), 100µL
of 5% alpha-Naphthol (N1000-10G, Sigma) in 95% ethanol, and 100µL of 40% KOH in
water. The mixture was vortexed then incubated at room temperature for 15 minutes. The
absorbance was measured at 560nm in a flat-bottomed 96-well plate.

Hemolytic Assay
OD of overnight cultures and timepoint cultures were measured at 600nm. 500µL
of cultures were centrifuged to obtain a bacterial pellet separate from supernatant. 100µL
of supernatant and 5µL of 0.1 M dithiothreitol were incubated at room temperature for 15
minutes in a round-bottom 96-well plate. A 1:2 serial dilution of these samples was
performed with 100µL of hemolytic assay buffer. The hemolytic assay buffer consisted
of 125 mM sodium chloride (Ameresco #0241-5KG, Framingham, MA, USA) and 35
mM sodium phosphate dibasic (Fisher 7558-79-4) adjusted to pH 5.5. Hemolytic assay
buffer was used to prepare defibrinated sheep blood at 2% hematocrit. 100µL of the
prepared blood was added to each well, and the samples were incubated at 37°C for 30
minutes. Intact blood cells were separated from the rest of the sample by centrifuging the
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plates at 2000 rpm for 5 minutes. 120µL of the supernatant was transferred to a flatbottom 96-well plate and the absorbance was measured at 541nm using a microplate
reader.

Cell Culture Infection
RAW264.7 macrophages were cultured at 37°C with 5% CO2 in Dulbecco’s
Modified Eagle Medium (DMEM; Corning 10-013-CV, Corning, NY, USA) containing
10% Fetal Bovine Serum (Corning 35-010-CV) and penicillin/streptomycin
(BioWhittaker 17-603E, Rockland, ME, USA). The macrophages were seeded 6x106
cells per plate in a 24-well plate and incubated at 37°C overnight. Listeria cultures were
grown overnight in their respective oxygen (aerobic and anaerobic) and SCFA conditions
(no supplement, Mhi, and Mlo). The cultures were centrifuged for 3 minutes at 10,000rpm,
washed, and resuspended in Phosphate-buffered Saline (PBS). Culture OD was used to
calculate the volume of bacterial culture suspension needed to achieve a multiplicity of
infection of 10. At 30 minutes post infection of the macrophages, the wells were washed
twice with Dulbecco’s PBS (DPBS) (World Wide Life Sciences, 61211088). DMEM
with 10µg/mL gentamicin was supplemented into the wells to remove extracellular
Listeria. Macrophages were lysed using 0.1% Triton-X at 2, 4, and 8 hours post infection.
The lysate was then plated on LB plates, which were incubated at 37°C for 2 days.
Colonies were counted by an aCOLyte 3 plate reader (Synbiosis) and then intracellular
colony forming units(CFUs)/well was calculated.
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Mouse Infections
For the old cohort of mice, 3 month old female BALB/c mice were purchased
from Jackson laboratory and aged in our vivarium until they were 16-18 months old. The
young female BALB/c cohort of mice were purchased at 2 months of age and acclimated
in our vivarium for 1 week. While in our vivarium, mice were aged/acclimated 4 to a
cage on a 12-hour light and 12-hour dark schedule. Once the experiment began, mice
were moved to individual cages and given designated SCFAs through drinking water.
These SCFA treatments were the no supplement control, 110mM acetate, 70mM
propionate, 20mM butyrate, Mhi, Mlo, and 200 mM NaCl. The drinking water was
replaced biweekly for the 5 weeks of the experiment. In order to find the amount of water
consumption for each mouse, before and after weights of the water bottles were recorded
during water replacement. The mice were weighed weekly to observe changes from
SCFA treatment and were familiarized with Nutella (the mode of infection) through
feeding.
After 28 days of SCFA treatment, the mice were starved for 24 hours before
infection. On the day of infection, the mice were each given 108 bacterial CFUs of either
the strain 10403s or 07PF0776 inside Nutella. 4 to 5 days post infection the mice were
euthanized by CO2 asphyxiation and their organs (heart, liver, spleen, gallbladder, colon,
and fecal contents of colon) were extracted. The organs were sonicated in 1% tergitol
NP-7 by a 60 sonic dismembrator. The organ homogenates were diluted and liver, spleen,
gallbladder, and heart samples were plated onto LB agar plates while ileum, colon, and
colonic content samples were plated on Oxford agar plates. The plates were incubated at
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37°C for 2 days and the colonies were counted using an aCOLyte 3 plate reader
(Synbiosis).

Results
SCFA Supplementation Affects LLO Production of Strains 10403s and 07PF0776
These experiments were performed mainly by Dr. Erica Rinehart, while I assisted
her in some of the hemolytic assays. Data for these experimental results have been
recently published,50 but will be described here. There are multiple important effects that
SCFA supplementation has on the LLO production of Listeria strains 10403s and
07PF0776, as noted by looking at hemolysis. Mlo supplementation leads to an increase of
LLO production while Mhi supplementation leads to a decrease of LLO production in
strain 10403s under aerobic conditions when compared to the no supplement control.
However, this is not seen in the 07PF0776 strain under aerobic conditions; Mlo
supplementation leads to a decrease of LLO production while Mhi supplementation leads
to no significant difference in LLO production. Under anaerobic conditions, there is no
production of LLO in the 10403s strain while there is in the 07PF0776 strain. SCFA
supplementation affects the 07PF0776 strain similarly under anaerobic conditions as it
did under aerobic conditions, however one important difference is that there is a
significant increase in LLO production when supplemented with Mhi that was not present
under aerobic conditions. Overall, there is clearly an oxygen concentration, strain, and
SCFA dependent difference on Listeria’s production of LLO.
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SCFA Supplementation Affects Carbon Metabolism of Strains 10403s and 07PF0776
There are multiple important effects that SCFA supplementation has on the
carbon metabolism of Listeria strains 10403s and 07PF0776, as noted by looking at
acetoin production. Under aerobic condition, Mlo supplementation leads to a significant
increase of acetoin production in the 07PF0776 strain, but not in the 10403s strain, while
Mhi supplementation leads to a significant increase of acetoin production in both strains.
There was also a significant increase of acetoin production in both strains under aerobic
conditions from Mhi supplementation when compared to Mlo. Acetoin production
occurred in both strains under anaerobic conditions, but SCFA supplementation did not
significantly affect it.
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Figure 2: Acetoin production in 10403s and 07PF0776 Listeria strains is affected by
the supplementation of SCFAs. The results were normalized using OD read at 600nm.
The results show the averages of three replicates with error measurements calculated
using standard deviation. * p<0.05, ** p<0.01, *** p<0.001. The results represent 6
independent experiments.
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SCFA Supplementation Affects Strains 10403s and 07PF0776 Infection of Cell Cultures
These experiments were performed mainly by Dr. Erica Rinehart, while I assisted
her in some of the seeding, infecting, plating, and colony counting. Data for these
experimental results have recently been published,50 but will be described here. There are
multiple important effects that pre-exposure of Listeria strains to SCFA has on cell
culture infections, as noted by looking at infections of RAW264.7 macrophages. Under
aerobic conditions, SCFA treatment significantly affected intracellular growth of the
10403s strain, with Mlo increasing growth and Mhi decreasing growth, but did not
significantly affect intracellular growth of the 07PF0776 strain. Under anaerobic
conditions, Mlo significantly decreased intracellular growth of the 10403s strain and Mhi
had no significant effect. However, there again is no significant effect of SCFA treatment
on the intracellular growth of the 07PF0776 strain grown anaerobically.
Another important result that came from this experiment is that it shows a
difference of intracellular growth between the strains. At 8 hours post infection under
both aerobic and aerobic conditions, the 07PF0776 strain has less intracellular survival
than the 10403s strain.

Age of Mice and SCFA Supplementation of Strains 10403s and 07PF0776 Affects
Infection of BALB/c Mice
These experiments were performed mainly by Dr. Erica Rinehart, while I assisted
her in some of the sonicating, diluting, and plating of the organs and colony counting.
Data for these experimental results are included in her doctoral thesis but will be
described here. There are multiple important effects that pre-exposure of female BALB/c
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mice to SCFA has on infection with Listeria strains. There is also an important impact
that age has on the infection of these mice. In both young and old mice, infection with the
07PF0776 strain leads to a higher bacterial load in the spleen than does infection with the
10403s strain. In the old mice infected with the 07PF0776 strain, SCFA treatment
resulted in increased bacterial burden, with there being a significantly higher bacterial
burden from treatment with Mhi than Mlo. Also, in old mice, infection with the 07PF0776
strain leads to a higher bacterial load in the gallbladder than does infection with the
10403s strain. Of the mice that were treated with acetate, young mice had a higher
bacterial load in the heart than old mice. And, lastly, old animals seemed to have lower
bacterial burden in the heart when treated by propionate, butyrate, and Mlo, but this
difference was only significant with Mlo.

Discussion
Overall, these findings are highly relevant and have an important impact on what
is known today about Listeria infections. These studies have shown that there is clearly
an oxygen concentration, strain, and SCFA treatment dependent difference on Listeria’s
infection of macrophages and production of LLO and acetoin. Because LLO plays
multiple roles in infection and pathogenesis, it is important to know that its production is
altered by SCFA levels found in the gut, and that the 10403s and 07PF0776 strains
respond differently in LLO production to alteration by different SCFA levels. Because
SCFA supplementation altered acetoin levels, it is likely that SCFA affect Listeria’s
carbon metabolism. The macrophage infections showed that there are notable differences
in the 10403s and 07PF0776 strains, both in terms of normal infection abilities and
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impact of SCFA pre-exposure. Also, there seems to be a difference between the effects of
SCFA on aerobic and anaerobic cultures, although the significance of this was not tested.
The mice infections led to multiple relevant findings. Firstly, some mouse organs seem to
be holding higher bacterial burden when infected by the 07PF0776 strain than the 10403s
strain, such as the spleen and gallbladder. Secondly, different SCFA treatments have
different affects in different areas of mice. Increasing SCFA concentrations may have
caused a higher 07PF0776 bacterial burden in the spleen of old mice, acetate treatment
may have increased susceptibility of young mice to infections of the heart, and
propionate, butyrate, and Mlo treatments may be able to protect old mice from infections
reaching the heart.

Future Directions
An example of a future direction of this project is that the mice experiments need
to be repeated. One reason for this is that this experiment has only taken place one time in
our lab. Another reason is because the n values of our experiment could be increased in
order to provide more ability to find significance in results.
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Project 3 – Effects of Oxygen Levels on Listeria Pathogenesis
Introduction
Oxygen Concentration Varies in the Intestines
Humans and most mammals are obligate aerobes, meaning that they need oxygen
to complete metabolic processes. Although these organisms need oxygen to survive in the
broad sense, some areas in the body exist where oxygen concentration is low
(microaerobic) or absent (anaerobic). Oxygen concentrations vary throughout different
regions of the gastrointestinal (GI) tract and tend to decrease from the proximal to the
distal regions.51 Differences in oxygen concentration in the GI tract impact the processes
that occur throughout it, such as bacterial growth. For example, it has been shown that
gut microbiota segregate radially in response to the oxygen gradient and there is an
increase in growth of oxygen-tolerant organisms on the mucosal surface due to its oxygen
abundance.52 Along with changes to the growth of these symbiotic bacteria comes altered
growth to pathogenic bacteria as well.

Enteric Pathogens are Facultative Anaerobes
Two examples of enteric pathogens that adjust components of pathogenesis due to
oxygen concentration are Shigella flexneri and Listeria. Shigella is a Gram-negative
enteropathogen that causes shigellosis, or bacillary dysentery.53 It enters host cells by
delivering invasion plasmid antigen (Ipa) effectors through a type three secretion system
(T3SS). Shigella contains the fnr gene which gives rise to the transcriptional activator
FNR, which increases the transcription of genes necessary for anaerobic pathways of
pathogenesis. It has been shown that anaerobic conditions lead to reduced Ipa secretion

P a g e | 27

and T3SS needle elongation in Shigella, likely regulated by FNR, to ready the pathogen
for infection.54

Listeria Produces Multiple Virulence Factors
Listeria infection typically begins with the ingestion of contaminated foods. The
bacterium then travels into the stomach and through the intestines. Listeria likely
translocates into the host through different mechanisms, with one study suggesting that
Listeria invades the intestinal epithelium.55 Two internalin proteins, InlA and InlB, which
are located on the Listeria membrane, are crucial to Listeria crossing the intestinal and
placental barriers. InlA works by binding to the transmembrane protein E-cadherin on the
intestinal epithelium, causing cytoskeletal rearrangements that induce internalization.56,57
As an intracellular pathogen, Listeria can spread from cell to cell and can disseminate
into peripheral organs very rapidly.58
There are a few processes that varying oxygen levels are known to affect in
Listeria. It has been found that compared to aerobically grown Listeria, anaerobically
grown Listeria was more efficient in entering host cells but less successful in intracellular
growth.59 This difference could contribute to the explanation of how pre-exposure of
Listeria to anaerobic conditions can alter pathogenesis as well as the microbial
community composition after infections.60 Moreover, the expression of LLO, a protein
produced by Listeria that forms pores in the phagosomal membrane to assist the bacterial
escape from phagosomes, is under strong regulation by oxygen concentration present
during growth. LLO protein is more abundant in aerobically grown Listeria compared to
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that in anaerobically grown Listeria.59 However, the underlying cause of the anaerobic
suppression of LLO production is not fully understood.

Listeria Produces Different Metabolites in Response to Oxygen Availability
Listeria growth under aerobic or anaerobic conditions can be easily distinguished
by the metabolites that are produced. For example, under aerobic, but not anaerobic,
conditions, Listeria produces acetylmethylcarbinol or acetoin.61 As a result, the
production of acetoin has been proposed as an indicator for Listeria contamination in
food products.62 In contrast, under anaerobic conditions, the production of lactic acid
dominates, contributing to the more pronounced acidification of culture media, compared
to growth under aerobic conditions.

Project Goals
One thing our research lab is dedicated to is gaining knowledge of how Listeria
responds to the presence or absence of oxygen. Although it has been established that
LLO production is higher in Listeria grown aerobically than anaerobically, the reason for
this is not fully understood. The main goal of this project is to better understand the
mechanism underlying the regulation of LLO production by varying oxygen levels, and
more specifically to consider the possibility that there is a post-transcriptional inhibition
of LLO in Listeria grown anaerobically.
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Materials and Methods
Strains
The Listeria strains used include the wild-type lab strain 10403s and an inducible
LLO (iLLO) strain.63 The iLLO strain is induced by addition of IPTG and allows for the
control of the level of hly transcription to assess post-transcriptional regulation. These
strains were streaked onto brain heart infusion (BHI) agar weekly.

Culture Conditions
Aerobic/Anaerobic Transition Experiments

Listeria strain 10403s was grown overnight in the filter sterilized defined media
described above. The overnight cultures were put into either an aerobic or anaerobic
environment. The aerobic cultures were placed into a 37°C incubator on a shaker while
the anaerobic cultures were placed into an anaerobic chamber and grown statically at
37°C (Type A, Coy Laboratory, Grass Lake, MI, USA). The gas inside the chamber
consists mostly of nitrogen with 2.5% hydrogen. 50mL conical tubes with 10mL and
15mL of inoculated BHI were placed into the anaerobic and anaerobic environments,
respectively. Optical density (OD) of the overnight cultures were read the next day by
transferring 200µL of each into a 96-well plate that was read at 600nm using a plate
reader (Synergy4, Biotek, Winooski, VT, USA).
The bacteria grown aerobically was concentrated into 1mL of BHI. 100µL of this
concentrated solution was used to inoculate 6 tubes of 3 mL BHI each. 3 of these were
then placed into the aerobic environment and 3 were placed in the anaerobic
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environment. The same was done to the anaerobic overnight cultures. After this,
hemolytic assays were performed at 2 and 4 hours of incubation.
Aerobic/Microaerobic/Anaerobic Experiments

The iLLO strain was grown overnight in the filter sterilized defined media
described above. The overnight cultures were put into either an aerobic, anaerobic, or
microaerobic environment. The aerobic cultures were placed into a 37°C incubator on a
shaker while the anaerobic cultures were placed into an anaerobic chamber and grown
statically at 37°C (Type A, Coy Laboratory, Grass Lake, MI, USA). The gas inside the
chamber consists mostly of nitrogen with 2.5% hydrogen. The microaerobic cultures
were placed into a small chamber along with a gas-pak that works to rid the air of
oxygen. The small chamber was then placed inside the 37°C incubator. It was placed at a
tilt to ensure adequate surface area of the cultures for gas exchange. 3 tubes consisting of
3mL of culture with 1mM IPTG were each placed in the aerobic, anaerobic, and
microaerobic conditions. Optical density (OD) of the overnight cultures were read the
next day by transferring 200µL of each into a 96-well plate that was read at 600nm using
a plate reader (Synergy4, Biotek, Winooski, VT, USA) and then a hemolytic assay was
performed.

Hemolytic Assay
Described in Project 2
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Results
Aerobic/Anaerobic Transition Experiments are Currently Inconclusive
6 trials of the aerobic/anaerobic transition experiments were conducted, with 3
being shown in Figure 3, and the results were inconclusive because of a wide variety of
responses. Although it was expected that there would be a higher amount of LLO
produced by 4 hours (T4) than 2 hours (T2) this occasionally was not the case. These
results also do not provide enough evidence to draw conclusions between the
environment of the cultures. It is important to note that these results are likely not due to
experimenter error throughout the trials, as the error measurements were typically very
small.
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Figure 3: The aerobic/anaerobic transition experiments yielded inconsistent levels of
hemolysis. Hemolysis was determined using a hemolytic assay and normalized by OD
read at 600nm. Hemolytic assays were performed 2 (T2) and 4 (T4) hours after
putting cultures into new environments. The results show the averages of three
replicates with error measurements calculated using standard deviation. The results
represent 3 of 6 independent experiments.
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Aerobic/Microaerobic/Anaerobic Experiments Give More Insight into Regulation of LLO
2 trials were conducted of the aerobic/microaerobic/anaerobic experiments, with 1
representative trial being shown in Figure 4. Lysis, which represents the presence of
LLO, is below detection (BD) in anaerobic samples and higher in aerobic samples.
Interestingly, though, microaerobic samples produced significantly more LLO than
aerobic samples.

Figure 4: The aerobic/microaerobic/anaerobic experiments yielded consistent levels
of hemolysis and demonstrated that there is not a linear response of LLO production
to varying oxygen levels. The results show the averages of three replicates with error
measurements calculated using standard deviation. * p<0.05, ** p<0.01, *** p<0.001.
The results represent 2 independent experiments.

Discussion
Because the results of the 6 aerobic/anaerobic transition experiments were
inconclusive, they did not help us to understand the regulation of LLO production by
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varying oxygen concentrations. However, this form of experiment is still very useful, as it
offers an important look at the difference between hly transcript and LLO produce in
aerobic as compared to anaerobic environments. In order to hopefully use these
experiments in the future for more conclusive results, they should be improved in the
ways discussed in the future directions.
The aerobic/microaerobic/anaerobic experiments did not prove our initial thought
that there may be a post-transcriptional inhibition of LLO in Listeria grown
anaerobically. This is because these experiments showed that there is not a linear
response of LLO production to varying oxygen levels. There may be some type of posttranscriptional modification taking place, but it is not linearly regulated by oxygen levels.
More research and duplications of these experiments need to be done in order to better
determine what is causing a low amount of LLO production in anaerobic cultures and a
high amount in microaerobic cultures.

Future Directions
There are multiple improvements that can be made to the aerobic/anaerobic
transition experiments that could possibly lead to better results. One improvement is that
the bacteria from the overnight cultures should be washed before switching environments
the next day. Without doing this, LLO that was previously synthesized likely skewed the
results somewhat. Another improvement that could be made is for the bacteria from the
overnight cultures to be normalized before switching environments. This may be a better
option than normalizing by OD. For the aerobic/microaerobic/anaerobic experiments,
qPCR should additionally be used in order to determine that IPTG is accurately
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functioning to produce the same amount of hly transcript in all of the varying oxygen
environments.

Appendix
PowerPoint and Poster Presentations
1. Berry Summer Thesis Institute Symposium, August 2018
2. Honors Student Symposium 2019, March 2019
3. American Society for Microbiology (ASM) Microbe 2019, June 2019
4. Honors Student Symposium 2020, March 2020
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